3Chakrabarti O, Veeraraghavalu K, Tergaonkar V, et al. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic ras. J Virol, 2004,78 (11):5934- 5945.
4Contrems-Paredes A, De la Cruz-Hemandez E, Martinez-Ramirez I, et al. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/ PI3K) signaling pathway. Virology, 2009,383 ( 1 ) :78-85.
5Xiaohong Wang, Hsu-Kun Wang, J. Philip Mccoy, Oncogenic HPV infection interrupts the expression of tumor-suppressive miR- 34a through viral oncoprotein. RNA,2009, 15:637-647.
6Song YS, Kee SH, Kim JW, et al. Major sequence variants in E7 gene of human papillomavirus type 16 from cercica~ cancerous and noncancerous lesions of Korean women. Gynecol Oncol, 1997,66 (2) :275-281.
7Marta Melax-New, Laimonis A. Laimins. Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins. J Virol, 2010,84: 5212- 5221.
8Horvath CA, Boulet GA, Renoux VM, et al. Mechanisms of cell entry by human papillomaviruses : an overview. Virol J, 2010,7 : 11.
9Sichem L, Ferreira S, Trottier H, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer, 2007, 120(8) :1763-1768.
10O'Connor M, Bernard HU. Oct-1 activates the epithelialspeeifie enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology, 1995,207 : 77-88.
